We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.20 | -13.33% | 1.30 | 1.20 | 1.40 | 1.30 | 1.05 | 1.25 | 2,479,405 | 10:28:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -3.71 | 1.76M |
Date | Subject | Author | Discuss |
---|---|---|---|
17/6/2020 21:06 | Contract news been leaked?! Why the 26% rise today? I have a few sell orders in encase it spikes high. | ilostthelot | |
17/6/2020 20:48 | AND if the worst did ever happen here... They will be there catching the assets for another time. This is how it works. | officerdigby | |
17/6/2020 20:46 | Stig, I know who wrote that - addressed to you? Means well enough but can be bad for your financial health. Be sure they were selling on the high ALWAYS, and getting in on the DISCOUNTED placements whenever ETC. Bear that in mind. | officerdigby | |
17/6/2020 20:39 | Superb read Stig | aimbagger | |
17/6/2020 19:56 | For newbies an old post by an ex-Founder of Physiomics expressing his opinion the stock is worth over 100p per share AND the justification for that VALUE by explaining the Industry dynamics and Physiomics significant assets and standing in this Industry. -------------------- Writing as a Founder of Physiomics I am a shareholder but do not represent the company in any capacity. WHY THIS SHARE IS WORTH A £1.00 giving it a market cap of still less than £60.million *It is first to market *Scarcity of trained personnel in what is still an emergent technology ( there are currently over a 1000 vacancies to be filled in this sector and few trained personnel ) *The development time needed to populate models and most importantly the availability of patient data that needs to be accessed apart from what is available in the literature is protracted PYC has been through this curve perfecting its models over time. * The Biometric Grant serves to demonstrate not only the faith in the company but also underpins the access PYC is being given to Patient data In this case in the field of Oesophgeal Cancer *Collaborations with major pharmas have been constrained whilst the models are perfected and due to the secretive nature of all pharmas who generally speaking do not want to share data. The latest contract has dramatically increased the visibility of what PYC do and do best and will encourage a raft of Biotech analysts to write it up as more contracts are announced *PYC's Cardiac Toxicity Model is 50% plus better than any other available on the market Why is this important? it is the major cause of attrition in clinical trials ( drug failure ) *The cost savings PYC is able to realise for major Pharma is key and further to small Biotechnology companies whose funding is limited as they try to move molecules into clinical trials. * Big Pharmas feed their development pipelines by acquiring or licensing in small bio's however these sales have moved progressively from Targets 20 years ago to IND candidates and onto Phase 1/2 putting the burden of proof onto the small Bio Techs who need to conserve and raise cash ( not easy and never has been ) *In 2010 Scientific American stated the cost of Development of a drug from start to finish FDA approval was $1.4 billion...In 2016 Association of British Pharmaceutical Industry Has upped this to £1.5 billion ( sterling) a really significant increase. NOTING that only 1 in 5000 drugs get final approval and this is not factored into the costs as above as representing only a successful transition of 1 drug to approval *In America alone $12-%14 billion per year is spent on Animal Testing Robert Solari a senior research fellow at Imperial College states "The predictive power of biology in reseach is relatively poor in research labs" and notes that the efficacy of animal testing are not particulary predictive of Human Efficacy PYC is "in Silico" ( in computer) its accuracy is one of its major plus points * PYC is striving to personalised medicine The HOLY GRAIL with tremendous Social and Financial Implications. * Sooner rather than later The FDA in America will have to recognise that rational drugs designed in computers can be tested in them too saving countless millions of development costs and most importantly time taken to approval ie move from the 20 to the 21st century * PYC has taken time to develop its excellent technology I believe I have cited the reasons for its true value. It has been challenged in recent times but has now become of age an is exceptionally well positioned in a market sector that is set to expand exponentially. To recap A leading British Technology currently way undervalued and one that is not a speculative BUY It has proven technology in a burgeoning sector and might well become the focus of an acquisition target as it is still so undervalued | the stigologist | |
17/6/2020 18:17 | Just needs to go up another 100% and I get my money back!!! | rv2 | |
17/6/2020 16:22 | Same lines* | spacedust | |
17/6/2020 16:09 | When it went to 11p few weeks ago from 3p the ssme.mines were written and posted on this very thread. One things for sure is that pyc disappoints more than.... whatever is the opposite of dissapoint is | spacedust | |
17/6/2020 16:01 | Lets hope there's substance to the rise. | mam fach | |
17/6/2020 15:54 | I'll be happy with 12p - 15p that means i get my investment back + a bonus | catchingmice | |
17/6/2020 15:44 | Those were awesome times for many. I bought at 9p after it dropped from 32p then jc started buyung and it went to 14p and I didn't sell. It was on its way up up up but Jim the cunning sold out his shares at 8p and then it was destroyed for good. Jc is the only hope | spacedust | |
17/6/2020 15:38 | Let's hope we see 32p again ? that was incredible when that happened, I thought I made a killing when sold for 100% ? | aimbagger | |
17/6/2020 15:38 | Going further north 6p by close | catchingmice | |
17/6/2020 15:34 | And the move from 32p to 2p? | spacedust | |
17/6/2020 15:26 | If this is a massive move what did you make the move to 11p from 3p | spacedust | |
17/6/2020 15:17 | Massive move | nw99 | |
17/6/2020 15:14 | I'm hoping jc comes back. He is our saving grace. Many sold out at recent spike to 11p recouping and breaking even. I missed it so I need jc back immediately. He is the only hope here | spacedust | |
17/6/2020 15:02 | Hopefully smash double digits on news, hit 10/11p recently without significant contract news. Happy to hold for when it lands. | aimbagger | |
17/6/2020 14:58 | JC had you all before be careful. | 412069 | |
17/6/2020 14:53 | Need this to finish 6.25p | spacedust | |
17/6/2020 14:51 | 99% JC buying and selling Look at recent move to 11p | spacedust | |
17/6/2020 14:50 | don't be bitter chesty just because you've missed out | wooster4 | |
17/6/2020 14:48 | Another PYC P&D | chesty1 | |
17/6/2020 14:25 | Come on JC put us out of our misery | spacedust | |
17/6/2020 14:08 | I could literally draw loads if golden crosses on the same chart | spacedust |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions